Literature DB >> 25582647

The epidemiology of Clostridium difficile infection inside and outside health care institutions.

Dale N Gerding1, Fernanda C Lessa2.   

Abstract

This article describes the global changes in Clostridium difficile epidemiology since the late twentieth century and into the twenty-first century when the new epidemic strain BI/NAP1/027 emerged. The article provides an overview of how understanding of C difficile epidemiology has rapidly evolved since its initial association with colitis in 1974. It also discusses how C difficile has spread across the globe, the role of asymptomatic carriers in disease transmission, the increased recognition of C difficile outside health care settings, the changes in epidemiology of C difficile infection in children, and the risk factors for disease. Published by Elsevier Inc.

Entities:  

Keywords:  Clostridium difficile infection; Community associated; Health care associated; Risk factors; Strain type

Mesh:

Year:  2015        PMID: 25582647     DOI: 10.1016/j.idc.2014.11.004

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  28 in total

Review 1.  Impact of microbial derived secondary bile acids on colonization resistance against Clostridium difficile in the gastrointestinal tract.

Authors:  Jenessa A Winston; Casey M Theriot
Journal:  Anaerobe       Date:  2016-05-07       Impact factor: 3.331

2.  Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291.

Authors:  Jenessa A Winston; Rajani Thanissery; Stephanie A Montgomery; Casey M Theriot
Journal:  J Vis Exp       Date:  2016-12-10       Impact factor: 1.355

Review 3.  Clostridium difficile Infection: An Epidemiology Update.

Authors:  Ana C De Roo; Scott E Regenbogen
Journal:  Clin Colon Rectal Surg       Date:  2020-02-25

Review 4.  Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.

Authors:  Leon Fisher; Alexander Fisher
Journal:  Clin Drug Investig       Date:  2017-07       Impact factor: 2.859

5.  The dangers of extreme body mass index values in patients with Clostridium difficile.

Authors:  Brian H Nathanson; Thomas L Higgins; William T McGee
Journal:  Infection       Date:  2017-06-07       Impact factor: 3.553

Review 6.  Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection.

Authors:  Brendan J Kelly; Pablo Tebas
Journal:  Chest       Date:  2017-09-18       Impact factor: 9.410

7.  Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes.

Authors:  Alice Y Guh; Yi Mu; Lisa G Winston; Helen Johnston; Danyel Olson; Monica M Farley; Lucy E Wilson; Stacy M Holzbauer; Erin C Phipps; Ghinwa K Dumyati; Zintars G Beldavs; Marion A Kainer; Maria Karlsson; Dale N Gerding; L Clifford McDonald
Journal:  N Engl J Med       Date:  2020-04-02       Impact factor: 91.245

8.  Clinical and economic benefits of fidaxomicin compared to vancomycin for Clostridium difficile infection.

Authors:  Jason C Gallagher; Joseph P Reilly; Bhagyashri Navalkele; Gemma Downham; Kevin Haynes; Manish Trivedi
Journal:  Antimicrob Agents Chemother       Date:  2015-08-31       Impact factor: 5.191

9.  Factors Associated With Complications of Clostridium difficile Infection in a Multicenter Prospective Cohort.

Authors:  Claire Nour Abou Chakra; Allison McGeer; Annie-Claude Labbé; Andrew E Simor; Wayne L Gold; Matthew P Muller; Jeff Powis; Kevin Katz; Julian R Garneau; Louis-Charles Fortier; Jacques Pépin; Suzanne M Cadarette; Louis Valiquette
Journal:  Clin Infect Dis       Date:  2015-09-03       Impact factor: 9.079

10.  1H, 13C, and 15N resonance assignments of an enzymatically active domain from the catalytic component (CDTa, residues 216-420) of a binary toxin from Clostridium difficile.

Authors:  Braden M Roth; Raquel Godoy-Ruiz; Kristen M Varney; Richard R Rustandi; David J Weber
Journal:  Biomol NMR Assign       Date:  2016-02-17       Impact factor: 0.746

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.